Last updated: March 10, 2024
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Overall Status: Active - Recruiting
Phase
N/A
Condition
Eye Disorders/infections
Retinitis Pigmentosa
Posterior Uveitis
Treatment
OCT, OCT angiography, flicker ERG and Ultra Wide Field retinography and autofluorescence.
Clinical Study ID
NCT06306690
6401
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients who are able to read and sign informed consent
- Patients with Retinitis pigmentosa confirmed by genetic test.
- Patients older than or equal to 18 years of age
Exclusion
Exclusion Criteria:
- Other retinal diseases such as macular hole, retinal detachment, macularneovascularization.
- Corneal surgery in the last 12 months
- Glaucoma with pressure above 25 mmHg in the last three months.
- Best Correct Visual Acuity below 1/10 in at least one eye.
Study Design
Total Participants: 35
Treatment Group(s): 1
Primary Treatment: OCT, OCT angiography, flicker ERG and Ultra Wide Field retinography and autofluorescence.
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
April 30, 2025
Study Description
Connect with a study center
Maria Cristina Savastano
Roma, 00198
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.